Rising's Generic Price Fixing Settlement Follows Bankruptcy, Cooperation
Executive SummaryRising Pharmaceuticals agrees to pay $3.1m, admits to conspiring to fix prices for hypertension drug, and enters into deferred prosecution agreement. Pfizer asks court to be removed from complaint by state AGs.
You may also be interested in...
Judge allows plaintiffs to argue attendance at trade association meetings and job-hopping show scheme to fix drug prices; confidentiality of attorney communication is in dispute.
Heritage agrees to pay $7.1m to resolve civil allegations and a $225,000 criminal penalty. DOJ defers prosecution of one felony charge.
Struggling US firm Aceto has filed Chapter 11 bankruptcy petitions at the same time as agreeing to divest its chemicals business assets for US$338 million, with plans to also offload its Rising Pharmaceuticals unit.